From 2003 to 2014, sepsis-associated mortality rates significantly declined in patients with cancer, yet these rates have remained relatively unchanged in patients without cancer.
Only one in four patients with sinonasal squamous cell carcinoma is tested for human papillomavirus.
In a study published in The Lancet Infectious Diseases, investigators demonstrated a significant gap in research on human T-cell lymphotropic virus type 1 (HTLV-1) and the effect of comorbidities on mortality in patients with this infection.
Risk for gastric cancer tied to H. pylori infection higher in blacks, Asians, Hispanics/Latinos
In 60-year follow-up, significantly lower lung cancer rates seen for those with childhood BCG vaccination
For patients with lymphoma, the dose and frequency of HBV, sex, Ann Arbor stage, and ibrutinib as part of the chemotherapy regimen are independent factors that affect the impact of the vaccine.
Between 2012 and 2016, there were an estimated 34,800 annual cases of HPV-related cancer in the United States, 92% of which were attributed to strains of the virus covered by the 9-valent HPV vaccine.
Study provides a portrait of wild-type AAV infection in the liver with an identification of molecular forms, viral genotypes, viral integrations, and helper virus relationship and with AAV insertions positive selected during HCC development on noncirrhotic liver, which challenges the concept of AAV as nonpathogenic.
In 2018, adolescent vaccination coverage in the United States continued to improve for meningococcal and HPV vaccines and remains high for tetanus and reduced diphtheria toxoids and acellular pertussis vaccine.
Bacillus Calmette Guérin (BCG) vaccination in childhood was associated with a reduced risk of lung cancer development in American Indian and Alaska Native (AI/AN) populations, according to findings from a 60-year follow-up of a clinical trial. The review analyzed a multicenter, randomized by alternation, placebo-controlled, single-blind clinical trial that was conducted from December 1935 to…
